Michael J. Alfant
Directeur/Membre du Conseil chez HEALIOS K.K.
Provenance du réseau au premier degré de Michael J. Alfant
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
On2 Technologies, Inc.
 On2 Technologies, Inc. Packaged SoftwareTechnology Services On2 Technologies, Inc. develops video compression technology. The company offers advanced video compression, video encoding and publishing, and solutions for chips and devices.
18
| Extinct | Packaged Software | 18 |
15
| Public Company | Pharmaceuticals: Major | 15 |
Tokyo American Club
 Tokyo American Club Movies/EntertainmentConsumer Services Tokyo American Club operates as a club which offers cultural, business and recreational activities and amenities. The company was founded in 1928 and is headquartered in Tokyo, Japan.
14
| Non-Profit Organization | Movies/Entertainment | 14 |
Binfinity AG
 Binfinity AG Internet Software/ServicesTechnology Services Binfinity AG operates digital asset exchange marketplace. The company was founded by Huw Rogers, and Vaughan Marks and is headquartered in Zug, Switzerland.
3
| Holding Company | Internet Software/Services | 3 |
Newport Ltd.
 Newport Ltd. Advertising/Marketing ServicesCommercial Services Newport Ltd. engages in the provision of consumer products and services. It offers micromarketing, branding, and prormotion. The company was founded on January 14, 1994 and is headquartered in Tokyo, Japan.
2
| Private Company | Advertising/Marketing Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael J. Alfant via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| THESTREET, INC. | Commercial Printing/Forms | Director/Board Member Director/Board Member | |
Othera Pharmaceuticals, Inc.
 Othera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2002, Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing treatments for ophthalmic diseases. Othera is also engaged in the discovery of a novel set of orally available compounds to address severe medical conditions including inflammatory and oncology-related diseases. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
| CAI INTERNATIONAL, INC. | Finance/Rental/Leasing | Chief Executive Officer | |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Corporate Officer/Principal | |
| NTT DOCOMO, INC. | Wireless Telecommunications | Corporate Officer/Principal | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree | |
Xenon Vision, Inc.
 Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree | |
| Waseda University | College/University | Undergraduate Degree Undergraduate Degree | |
Hantro Products Oy
 Hantro Products Oy Electronic Production EquipmentElectronic Technology Hantro Products Oy develops wireless video solutions for hardware and semiconductor manufacturers. Its products include software coding technologies, video, audio and still image codecs, application components, middleware and graphical user interface. The company was founded by Eero Kaikkonen in 1992 and is headquartered in Oulu, Finland | Electronic Production Equipment | Chairman Chief Executive Officer | |
San Francisco Opera Association
 San Francisco Opera Association Movies/EntertainmentConsumer Services San Francisco Opera Association owns and operates opera theater. It offers an array of training programs and performance opportunities for young artists under the support of the San Francisco Opera Center and the Merola Opera Program. The company was founded by Gaetano Merola in 1923 and is headquartered in San Francisco, CA. | Movies/Entertainment | Director/Board Member | |
| Kyushu University | College/University | Doctorate Degree | |
| ACUCELA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Pharmaceuticals: Major | Chief Executive Officer | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| Itel Containers International Corp. | Sales & Marketing | ||
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Chairman Director/Board Member | |
| Kyoto University of Foreign Studies | College/University | Undergraduate Degree | |
| Kagimoto Holdings KK | President | ||
| Sighregen Co., Ltd. | President Comptroller/Controller/Auditor Director/Board Member | ||
| Ophthaconsult LLC | Founder | ||
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| BLACKRIDGE TECHNOLOGY INTERNATIONAL, INC. | Packaged Software | Sales & Marketing Director/Board Member | |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Biotechnology | Director/Board Member | |
Vermilion Capital Management Ltd.
 Vermilion Capital Management Ltd. Investment ManagersFinance Vermilion Capital Management Ltd. engages in providing investment advice and business consulting services. It offers the vermilion gateway to real estate investment, fund management, advisory and consulting services. The company is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
jCyte, Inc.
 jCyte, Inc. Medical/Nursing ServicesHealth Services jCyte, Inc. engages in the provision of retinal therapies. Its therapy focuses with retinitis pigmentosa, and retinal progenitor cells. The company was founded by Terry O?Neal, Henry Klassen and Jing Yang in 2012 and is headquartered in Newport Beach, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Healios N.A., Inc. | President Chief Executive Officer Director/Board Member | ||
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Founder | |
| OCUPHIRE PHARMA, INC. | Pharmaceuticals: Major | Chairman | |
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Director/Board Member Founder | |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 37 |
| Japon | 10 |
| Royaume-Uni | 3 |
| Finlande | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 105 |
| Corporate Officer/Principal | 67 |
| President | 29 |
| Independent Dir/Board Member | 23 |
| Founder | 19 |
Relations les plus connectées
| Insiders | |
|---|---|
| Cam Gallagher | 24 |
| J. Kosowsky | 16 |
| Gregory Bonfiglio | 16 |
| John Fargis | 13 |
| Jun Narimatsu | 12 |
| Atsushi Abe | 12 |
| Balraj Joll | 12 |
| Thomas E. Weigman | 11 |
| Hiromitsu Ogawa | 10 |
| Pekka Sakari Salonoja | 10 |
| Afsaneh Naimollah | 9 |
| Hardy Kagimoto | 9 |
| Al Reaves | 9 |
| Jonathan Yeh | 8 |
| Richard Kincaid | 7 |
- Bourse
- Insiders
- Michael J. Alfant
- Connexions Sociétés
